Skip to main content

Table 1 The constant of Ksv, Kq, Kb and the number of binding sites (n) for 2b and hTF

From: A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway

 

Ksv * 105 (L mol−1)

Kq * 1013 (L mol−1 s−1)

Number of binding sites (n)

Kb * 105 (L mol−1)

2b

1.09

1.89

1.1

3.97